These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


466 related items for PubMed ID: 1912029

  • 1. Incidence and clinical risk factors for bleeding and thrombotic complications in myeloproliferative disorders. A retrospective analysis of 260 patients.
    Wehmeier A, Daum I, Jamin H, Schneider W.
    Ann Hematol; 1991 Aug; 63(2):101-6. PubMed ID: 1912029
    [Abstract] [Full Text] [Related]

  • 2. Myeloproliferative disorders: complications, survival and causes of death.
    Brodmann S, Passweg JR, Gratwohl A, Tichelli A, Skoda RC.
    Ann Hematol; 2000 Jun; 79(6):312-8. PubMed ID: 10901610
    [Abstract] [Full Text] [Related]

  • 3. Bleeding and thrombosis in chronic myeloproliferative disorders: relation of platelet disorders to clinical aspects of the disease.
    Wehmeier A, Scharf RE, Fricke S, Schneider W.
    Haemostasis; 1989 Jun; 19(5):251-9. PubMed ID: 2777137
    [Abstract] [Full Text] [Related]

  • 4. [Diagnosis and treatment of BCR/ABL-negative myeloproliferative diseases--principles and rationale of CZEMP recommendations].
    Schwarz J, Penka M, Campr V, Pospísilová D, Kren L, Nováková L, Bodzásová C, Brychtová Y, Cerná O, Dulícek P, Joniásová A, Kissová J, Korístek Z, Schützová M, Vonke I, Walterová L.
    Vnitr Lek; 2011 Feb; 57(2):189-213. PubMed ID: 21416861
    [Abstract] [Full Text] [Related]

  • 5. Polycythemia vera and essential thrombocythemia: 2012 update on diagnosis, risk stratification, and management.
    Tefferi A.
    Am J Hematol; 2012 Mar; 87(3):285-93. PubMed ID: 22331582
    [Abstract] [Full Text] [Related]

  • 6. Therapeutic dilemmas: balancing the risks of bleeding, thrombosis, and leukemic transformation in myeloproliferative disorders (MPD).
    Murphy S.
    Thromb Haemost; 1997 Jul; 78(1):622-6. PubMed ID: 9198227
    [Abstract] [Full Text] [Related]

  • 7. Polycythemia vera and essential thrombocythemia: 2019 update on diagnosis, risk-stratification and management.
    Tefferi A, Barbui T.
    Am J Hematol; 2019 Jan; 94(1):133-143. PubMed ID: 30281843
    [Abstract] [Full Text] [Related]

  • 8. Prediction of thrombotic and hemorrhagic events during polycythemia vera or essential thrombocythemia based on leukocyte burden.
    Lim Y, Lee JO, Kim SH, Kim JW, Kim YJ, Lee KW, Lee JS, Bang SM.
    Thromb Res; 2015 May; 135(5):846-51. PubMed ID: 25743883
    [Abstract] [Full Text] [Related]

  • 9. Relation of platelet abnormalities to thrombosis and hemorrhage in chronic myeloproliferative disorders.
    Wehmeier A, Südhoff T, Meierkord F.
    Semin Thromb Hemost; 1997 May; 23(4):391-402. PubMed ID: 9263357
    [Abstract] [Full Text] [Related]

  • 10. Clinical and laboratory features, pathobiology of platelet-mediated thrombosis and bleeding complications, and the molecular etiology of essential thrombocythemia and polycythemia vera: therapeutic implications.
    Michiels JJ, Berneman Z, Van Bockstaele D, van der Planken M, De Raeve H, Schroyens W.
    Semin Thromb Hemost; 2006 Apr; 32(3):174-207. PubMed ID: 16673274
    [Abstract] [Full Text] [Related]

  • 11. Fertility, pregnancy and the management of myeloproliferative disorders.
    Griesshammer M, Bergmann L, Pearson T.
    Baillieres Clin Haematol; 1998 Dec; 11(4):859-74. PubMed ID: 10640221
    [Abstract] [Full Text] [Related]

  • 12. Hemorrhagic and thrombotic complications in patients with myeloproliferative diseases.
    Vignal CV, Lourenço DM, Noguti MA, Chauffaille Mde L, Kerbauy J.
    Sao Paulo Med J; 1997 Dec; 115(6):1575-9. PubMed ID: 9640794
    [Abstract] [Full Text] [Related]

  • 13. Thrombohemorrhagic events, disease progression, and survival in polycythemia vera and essential thrombocythemia: a retrospective survey in Miyazaki prefecture, Japan.
    Kamiunten A, Shide K, Kameda T, Sekine M, Kubuki Y, Ito M, Toyama T, Kawano N, Marutsuka K, Maeda K, Takeuchi M, Kawano H, Sato S, Ishizaki J, Akizuki K, Tahira Y, Shimoda H, Hidaka T, Yamashita K, Matsuoka H, Shimoda K.
    Int J Hematol; 2018 Jun; 107(6):681-688. PubMed ID: 29488167
    [Abstract] [Full Text] [Related]

  • 14. Polycythemia vera and essential thrombocythemia in young patients.
    Frezzato M, Ruggeri M, Castaman G, Rodeghiero F.
    Haematologica; 1993 Jun; 78(6 Suppl 2):11-7. PubMed ID: 8039752
    [Abstract] [Full Text] [Related]

  • 15. Propensity for hemorrhage and thrombosis in chronic myeloproliferative disorders.
    Kessler CM.
    Semin Hematol; 2004 Apr; 41(2 Suppl 3):10-4. PubMed ID: 15190517
    [Abstract] [Full Text] [Related]

  • 16. Polycythemia vera and essential thrombocythemia: 2013 update on diagnosis, risk-stratification, and management.
    Tefferi A.
    Am J Hematol; 2013 Jun; 88(6):507-16. PubMed ID: 23695894
    [Abstract] [Full Text] [Related]

  • 17. Chronic myeloproliferative disorders.
    Spivak JL, Barosi G, Tognoni G, Barbui T, Finazzi G, Marchioli R, Marchetti M.
    Hematology Am Soc Hematol Educ Program; 2003 Jun; ():200-24. PubMed ID: 14633783
    [Abstract] [Full Text] [Related]

  • 18. Budd-Chiari syndrome and thrombosis of other abdominal vessels in the chronic myeloproliferative diseases.
    Anger BR, Seifried E, Scheppach J, Heimpel H.
    Klin Wochenschr; 1989 Aug 17; 67(16):818-25. PubMed ID: 2796252
    [Abstract] [Full Text] [Related]

  • 19. Splenectomy after portal thrombosis in patients with polycythemia vera and essential thrombocythemia.
    Randi ML, Fabris F, Ruzzon E, Pacquola E, Cella G, Girolami A.
    Haematologica; 2002 Nov 17; 87(11):1180-4. PubMed ID: 12414348
    [Abstract] [Full Text] [Related]

  • 20. Clinical Manifestations and Risk Factors for Complications of Philadelphia Chromosome-Negative Myeloproliferative Neoplasms.
    Duangnapasatit B, Rattarittamrong E, Rattanathammethee T, Hantrakool S, Chai-Adisaksopha C, Tantiworawit A, Norasetthada L.
    Asian Pac J Cancer Prev; 2015 Nov 17; 16(12):5013-8. PubMed ID: 26163633
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 24.